These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TrkC promotes colorectal cancer growth and metastasis. Kim MS, Suh KW, Hong S, Jin W. Oncotarget; 2017 Jun 20; 8(25):41319-41333. PubMed ID: 28455963 [Abstract] [Full Text] [Related]
4. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis. Hu H, Wang M, Wang H, Liu Z, Guan X, Yang R, Huang R, Tang Q, Zou C, Wang G, Gao X, Wang X. Cell Physiol Biochem; 2018 Jun 20; 46(5):1895-1906. PubMed ID: 29719292 [Abstract] [Full Text] [Related]
5. Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance. Liu Z, Chen J, Yuan W, Ruan H, Shu Y, Ji J, Wu L, Tang Q, Zhou Z, Zhang X, Cheng Y, He S, Shu X. Cancer Sci; 2019 Jan 20; 110(1):86-98. PubMed ID: 30320939 [Abstract] [Full Text] [Related]
7. GDF15 promotes EMT and metastasis in colorectal cancer. Li C, Wang J, Kong J, Tang J, Wu Y, Xu E, Zhang H, Lai M. Oncotarget; 2016 Jan 05; 7(1):860-72. PubMed ID: 26497212 [Abstract] [Full Text] [Related]
8. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway. Chen J, Yuan W, Wu L, Tang Q, Xia Q, Ji J, Liu Z, Ma Z, Zhou Z, Cheng Y, Shu X. Oncotarget; 2017 Feb 07; 8(6):9961-9973. PubMed ID: 28035069 [Abstract] [Full Text] [Related]
9. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Wu Y, Peng Y, Wu M, Zhang W, Zhang M, Xie R, Zhang P, Bai Y, Zhao J, Li A, Nan Q, Chen Y, Ren Y, Liu S, Wang J. Oncotarget; 2016 Aug 09; 7(32):51150-51162. PubMed ID: 27223064 [Abstract] [Full Text] [Related]
10. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling. Xia YZ, Shan GF, Yang H, Zha J, Wang L, Chen JM, Zhang XS. Chem Biol Interact; 2021 Apr 25; 339():109424. PubMed ID: 33617803 [Abstract] [Full Text] [Related]
16. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling. Liu Z, Wang N, Wang F, Zhang S, Ding J. Biosci Rep; 2019 Nov 29; 39(11):. PubMed ID: 31693738 [Abstract] [Full Text] [Related]
17. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer. Qin Y, Tang B, Hu CJ, Xiao YF, Xie R, Yong X, Wu YY, Dong H, Yang SM. Oncotarget; 2016 Jan 05; 7(1):351-61. PubMed ID: 26540342 [Abstract] [Full Text] [Related]
18. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition. Zhao S, Sun H, Jiang W, Mi Y, Zhang D, Wen Y, Cheng D, Tang H, Wu S, Yu Y, Liu X, Cui W, Zhang M, Sun X, Zhou Z, Peng Z, Yan D. Mol Cancer; 2017 Jan 17; 16(1):12. PubMed ID: 28095858 [Abstract] [Full Text] [Related]
19. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression. Zhang Y, Li KF. Biomed Pharmacother; 2019 Dec 17; 120():109127. PubMed ID: 31629952 [Abstract] [Full Text] [Related]
20. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer. Min J, Liu L, Li X, Jiang J, Wang J, Zhang B, Cao D, Yu D, Tao D, Hu J, Gong J, Xie D. Sci Rep; 2015 Nov 13; 5():16578. PubMed ID: 26564738 [Abstract] [Full Text] [Related] Page: [Next] [New Search]